Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

NCT07631884 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors
Neoplasms (Cancer / Tumors)
Advanced Malignant Solid Neoplasm
Locally Advanced Malignant Solid Neoplasm
Unresectable Malignant Solid Neoplasm
Metastatic Malignant Solid Neoplasm
HER2 Expression
Biliary Tract Neoplasms
Endometrial Neoplasms
Urothelial Carcinoma (UC)
Pancreatic Neoplasms
Colorectal Neoplasms
Gastric Neoplasms
Non-Small Cell Lung Carcinoma (NSCLC)
Head and Neck Neoplasms
Cervical Neoplasms

Interventions

DRUG: Trastuzumab Rezetecan

Sponsor

Haihua Yuan